Skip to Content

Silodosin Pregnancy and Breastfeeding Warnings

Silodosin is also known as: Rapaflo

Silodosin Pregnancy Warnings

Animal studies have failed to reveal evidence of teratogenicity or fetotoxicity. Animal studies have revealed decreased fertility at about twice the maximum recommended human dose (MRHE), decreased sperm count and viability at about 65 times the MRHE, and histopathological changes in the testes and epididymides at about 30 times the MRHE. Decreased fertility was reversible following a 2 week recovery period. There are no controlled data in human pregnancy. US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

This drug is not indicated for use in female patients. US FDA pregnancy category: B

See references

Silodosin Breastfeeding Warnings

Major: This drug is not indicated for use in female patients. Excreted into human milk: Data not available Excreted into animal milk: Data not available

See references

References for pregnancy information

  1. "Product Information. Rapaflo (silodosin)." Watson Pharmaceuticals, Corona, CA.

References for breastfeeding information

  1. "Product Information. Rapaflo (silodosin)." Watson Pharmaceuticals, Corona, CA.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.